ZZPZH(SH:600436) Sou Hu Cai Jing·2025-09-28 22:53Core Viewpoint - The announcement details the resignation of Yang Haipeng as a director and chief accountant of Zhangzhou Pianzaihuang Pharmaceutical Co., Ltd., and the company's decision to invest in the Zhongjin Medical Fund, which aligns with its long-term development strategy and aims to enhance its core competitiveness and overall value [1][4][5]. Group 1: Management Changes - Yang Haipeng has submitted his resignation due to work adjustments, but will continue to serve as an advisor [1]. - His resignation does not affect the legal number of board members and will not disrupt the company's normal operations [2]. - The company expresses gratitude for Yang's contributions during his tenure [2]. Group 2: Investment in Zhongjin Medical Fund - The company plans to invest RMB 200 million in the Zhongjin Medical Fund, which has a target fundraising scale of RMB 1 billion, making the company's contribution 20% of the total [6][10]. - The investment focuses on the healthcare sector, including traditional Chinese medicine, biomedicine, medical devices, and related industries [6][34]. - The investment is a joint effort with related parties and does not constitute a major asset restructuring as defined by regulations [6][11]. Group 3: Approval Process - The investment proposal has been approved by the company's independent directors, audit committee, and board of directors, ensuring compliance with legal and regulatory requirements [41][42][44][45]. - The decision to invest does not require submission to the shareholders' meeting [5][41]. Group 4: Financial Impact - The investment is not expected to have a significant adverse impact on the company's financial status or operational performance [8][40]. - The funding for the investment will come from the company's own or raised funds, ensuring that operational capital needs are met [40]. Group 5: Fund Management and Structure - Zhongjin Medical Fund will be managed by Zhongjin Capital, a subsidiary of China International Capital Corporation, which has a strong reputation in private equity investment [39][12]. - The fund's management structure includes an investment decision committee responsible for major investment decisions [29]. Group 6: Compliance and Fairness - The investment transaction adheres to principles of fairness, voluntariness, and reasonableness, ensuring no harm to the interests of the company and minority shareholders [5][38].